SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS

Clinical trials for SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS trials appear

Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Personalized cell therapy tested for Hard-to-Treat scleroderma

Disease control Ongoing

This early-stage study is testing a new personalized cell therapy called KYV-101 for adults with active, diffuse systemic sclerosis (scleroderma). The therapy involves modifying a patient's own immune cells to target and remove certain B-cells thought to drive the disease. The ma…

Matched conditions: SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS

Phase: PHASE1, PHASE2 • Sponsor: Kyverna Therapeutics • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS

Get alerted when new SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS trials appear

Personalized cell therapy tested for Hard-to-Treat scleroderma